Clinical Trials Logo

Clinical Trial Summary

This is a phase 3, open-label, multicenter, randomized controlled phase III clinical trial. The purpose of this study is to evaluate the efficacy of ulinastatin, a kind of protease inhibitor, in the treatment of radiation-induced acute oral mucositis in localregionally advanced nasopharyngeal carcinoma(NPC) patients treated with concurrent chemoradiotherapy(CCRT). To Explore a new and efficient way to reduce the incidence and severity of radiation-induced acute oral mucositis.


Clinical Trial Description

Radiation-induced acute oral mucositis (RTOM) in Nasopharyngeal Carcinoma (NPC) patients treat with concurrent chemoradiotherapy (CCRT) is common. Currently, there is no effective treatment for RTOM. Ulinastatin, is a kind of natural anti-inflammatory substance. And this substance is insufficient when the body's inflammatory response is strongly. There are a series of studies have confirmed the efficacy and safety of ulinastatin in the treatment of body's inflammatory response. From the observation of our previous clinical practice, we found that ulinastatin can relieve the severity of RTOM. The present study is undertaken to evaluate the efficacy of ulinastatin in the treatment of RTOM in localregionally advanced NPC patients treated with CCRT. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03387774
Study type Interventional
Source Sun Yat-sen University
Contact
Status Active, not recruiting
Phase Phase 3
Start date January 30, 2018
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT01318889 - Dexpanthenol Mouthwash to Treat Oral Mucositis Phase 2
Recruiting NCT06285591 - Lactobacillus Reuteri Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors N/A
Completed NCT04699487 - Efficacy and Safety of CareMin650 for Prevention of Oral Mucositis in HNC Patients Starting Radiotherapy N/A
Not yet recruiting NCT05664906 - Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients Phase 1/Phase 2
Completed NCT03833570 - Melatonin for Prevention of Radiation Induced Oral Mucositis Phase 2
Recruiting NCT05322421 - Effectiveness of Topical Olive Oil in Prevention and Management of Radiation Induced Oral Mucositis N/A
Active, not recruiting NCT03972527 - Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients N/A
Recruiting NCT06354712 - Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients. Phase 2